|
|
|
By Michael Riddle Jr., Mesogen Inc. | Advances in autologous stem cell and biomaterial engineering are transforming the future of regenerative medicine by enabling scalable, patient-derived therapies. | |
|
|
|
| How Beta-lactams Can Pose A Risk To Your CGTs | Article | FUJIFILM Biosciences | Beta-lactam antibiotics pose an invisible contamination risk to CGTs, threatening patient safety and regulatory compliance. Review essential mitigation steps to protect patient safety and ensure regulatory compliance. |
|
|
|
| Vector Copy Number (VCN) Quantification Using QIAcuity Digital PCR | Application Note | By Anne Schieren, Philipp Rink, Anida Mesihovic Karamitsos, et al., QIAGEN | Explore a faster approach to vector copy number measurement that replaces DNA extraction with direct cell lysis and digital PCR, delivering accurate, reproducible results across fresh and frozen samples. |
|
|
| Automated DNA Clean-Up Using Magnetic Bead-Based Methods | Application Note | INTEGRA Biosciences | Discover how to improve DNA clean‑up through a precise magnetic bead–based workflow, as well as how optimized liquid handling enhances yield, purity, and reproducibility for higher confidence in results. |
|
|
| What Are MSCs And How Are They Used? | Article | Corning Life Sciences | Mesenchymal stem cells are vital to emerging regenerative treatments. This overview outlines their defining biological criteria, diverse tissue sources, and clinical applications. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|